24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Sanofi
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
18:02
Rapyd raises $500M at $4.5B valuation to complete $610M PayU acquisition
15:31
Where will US markets find their bottom? A model points to a potential 11% drop
14:58
Matrix looks to Wall Street: $2.1 billion merger could pave way for Nasdaq listing
14:14
IAI reports record $6.1 billion in sales as global demand for weapons surges
More stories
Buzz
Most popular
Daily
Weekly
1
Rapyd raises $500M at $4.5B valuation to complete $610M PayU acquisition
2
"Eventually, AI will surpass us in everything"—so what skills will still matter?
3
Cyber unicorn Pentera raises $60M at over $1B valuation as ARR approaches $100M
4
Cyber startup ActiveFence cuts 7% of workforce
5
Sola Security aims to be the Wix of cyber with $30 million Seed round
More news
Sanofi
5 stories about Sanofi
Teva’s stock surge comes to a halt, falling 14% amid weak 2025 outlook
30.01.25
|
Sophie Shulman
Despite a strong 80% gain in 2024, Teva’s stock dropped after the company revealed disappointing profitability and cash flow forecasts.
Teva’s 10-year turnaround takes shape with stunning trial results
18.12.24
|
Sophie Shulman
Duvakitug signals a brighter future for the Israeli pharma giant.
Teva shares jump as its most promising drug shows exceptional trial results
17.12.24
|
Sophie Shulman
Duvakitug, designed to treat colitis and Crohn’s disease, exceeded expectations and positions Teva to compete in the $28 billion global market for inflammatory bowel disease treatments.
Nucleai raises $33 million for spatial biology drug development platform
22.03.22
|
Meir Orbach
The technology developed at the Israeli startup allows better prediction of the patient's response to specific oncological treatment, saves on the ongoing process of testing different drugs and improves the chances of the development of new cancer drugs
Medisafe raises $30 million in Series C led by pharma giant Sanofi
25.02.21
|
Meir Orbach
The company expanded its platform in 2020 with the launch of Medisafe Care Connector, which digitally connects patients and doctors